APA

Vockley J., Burton B., Berry G. T., Longo N., Phillips J., Sanchez-Valle A., Tanpaiboon P., Grunewald S., Murphy E., Bowden A., Chen W., Chen C., Cataldo J., Marsden D. & Kakkis E. (20200401). Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD). : Journal of inherited metabolic disease.

Chicago

Vockley Jerry, Burton Barbara, Berry Gerard T, Longo Nicola, Phillips John, Sanchez-Valle Amarilis, Tanpaiboon Pranoot, Grunewald Stephanie, Murphy Elaine, Bowden Alexandra, Chen Wencong, Chen Chao-Yin, Cataldo Jason, Marsden Deborah and Kakkis Emil. 20200401. Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD). : Journal of inherited metabolic disease.

Harvard

Vockley J., Burton B., Berry G. T., Longo N., Phillips J., Sanchez-Valle A., Tanpaiboon P., Grunewald S., Murphy E., Bowden A., Chen W., Chen C., Cataldo J., Marsden D. and Kakkis E. (20200401). Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD). : Journal of inherited metabolic disease.

MLA

Vockley Jerry, Burton Barbara, Berry Gerard T, Longo Nicola, Phillips John, Sanchez-Valle Amarilis, Tanpaiboon Pranoot, Grunewald Stephanie, Murphy Elaine, Bowden Alexandra, Chen Wencong, Chen Chao-Yin, Cataldo Jason, Marsden Deborah and Kakkis Emil. Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD). : Journal of inherited metabolic disease. 20200401.